Andera Partners News Today

Dublin-based FIRE1 today announced that the first Irish patient has been successfully implanted with its FIRE1 System for remote heart failure monitoring. The innovative system has the potential to positively

/PRNewswire/ -- Grey Wolf Therapeutics ("Grey Wolf" or "the company"), a clinical-stage biotechnology company leveraging first-of-its-kind antigen modulation...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Grey Wolf Therapeutics Closes Oversubscribed $50 Million Series B Financing Expansion, Led by ICG Life Sciences, to Accelerate and Expand First-of-its-Kind Antigen Modulation Technology

Regulatory News: Tikehau Capital :   Strong growth in Asset Management AuM1     €44.1bn   at 31 March 2024   +13%   YoY growth ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Apr 6, 2024--

Berlin, Germany, 4 April 2024 - Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announces that it will be presenting a poster, demonstrating its new findings on the discovery of novel macrocyclic...

/PRNewswire/ -- Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain...

/PRNewswire/ -- Flamingo Therapeutics ("Flamingo") today announced its participation in the following upcoming investor and industry conferences: 23rd Annual...

PRESS RELEASE Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer Paris, France and Munich, Germany, March 25, 2024 – TRiCares SAS (“TRiCares”) a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, today is pleased to announce the appointment of Ahmed Elmouelhi as President & Chief Executive Officer (CEO). In conjunction with this, and following eight years at the helm of the busin...